目的 探討p16蛋白在乳腺癌中的表達及其臨床意義。
方法 采用LSAB免疫組化法對107例乳腺癌標(biāo)本進行p16蛋白的檢測。
結(jié)果 p16蛋白陽性率為40.19%(43/107)，生存時間≤5年，＞10年p16蛋白陽性率分別為8.00%和75.68%，p16蛋白表達陽性者生存時間明顯長于陰性者。
結(jié)論 p16蛋白的檢測是判斷乳腺癌預(yù)后的重要因素。
引用本文： 楊金巧,周蕾蕾,趙俊玲. p16蛋白在乳腺癌中的表達及其臨床意義. 中國普外基礎(chǔ)與臨床雜志, 2000, 7(5): 297-298. doi: 復(fù)制
| 1. | Lee SH. The histochemistry of estrogen receptors 〔Ｊ〕. Histochemistry, 1981; 71(1)∶291. |
| 2. | McCarthy KS, Larrg S, Edwin B, et al. Estrogen receptor analysis 〔Ｊ〕. Arch Pathol Lab Med, 1985; 109(1)∶716. |
| 3. | Walker DG, Duan W, Popovic EA, et al. Homozygous deletions of the multiple tumor suppressor gene 1 in the progression of human astrocytomas 〔Ｊ〕. Cancer Res, 1995; 55(1)∶20. |
| 4. | Kamb A, Cruis NA, Feldhaus JW, et al. A cell cycle regulator potentially involved in genesis of many tumor types 〔Ｊ〕. Science, 1994; 264(5)∶436. |
- 1. Lee SH. The histochemistry of estrogen receptors 〔Ｊ〕. Histochemistry, 1981; 71(1)∶291.
- 2. McCarthy KS, Larrg S, Edwin B, et al. Estrogen receptor analysis 〔Ｊ〕. Arch Pathol Lab Med, 1985; 109(1)∶716.
- 3. Walker DG, Duan W, Popovic EA, et al. Homozygous deletions of the multiple tumor suppressor gene 1 in the progression of human astrocytomas 〔Ｊ〕. Cancer Res, 1995; 55(1)∶20.
- 4. Kamb A, Cruis NA, Feldhaus JW, et al. A cell cycle regulator potentially involved in genesis of many tumor types 〔Ｊ〕. Science, 1994; 264(5)∶436.